The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma

PHASE3RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

October 31, 2019

Study Completion Date

October 31, 2025

Conditions
Diffuse Large B-cell Lymphoma
Interventions
RADIATION

Consolidation involved-site radiotherapy (ISRT)

"6 cycles modern CHOP chemotherapy followed consolidation involved-site radiotherapy (ISRT).~Involved-site radiotherapy (ISRT) is based on defining the site of gross disease before chemotherapy, the GTV and using a CT-based volume with an expansion to form a CTV in the cranio-caudal direction.~The general dose had been guided that 30-36Gy in 15\~18 fractions of 2 Gy 5 days per week was managed for patients with complete response (CR) after chemotherapy and 40-50Gy in 20\~25 fractions of 2 Gy 5 days per week for partial response (PR)."

RADIATION

Consolidation involved-field radiotherapy (IFRT)

"6 cycles modern CHOP chemotherapy followed consolidation involved-field radiotherapy (IFRT).~Radiotherapy field of IFRT defined by CALGB is encompassed the prechemotherapy gross tumor.~The general dose had been guided that 30-36Gy in 15\~18 fractions of 2 Gy 5 days per week was managed for patients with complete response (CR) after chemotherapy and 40-50Gy in 20\~25 fractions of 2 Gy 5 days per week for partial response (PR)."

DRUG

cyclophosphamide

Patients in both arms will be given cyclophosphamide chemotherapy

DRUG

doxorubicin

Patients in both arms will be given doxorubicin chemotherapy

DRUG

vincristine

Patients in both arms will be given vincristine chemotherapy

DRUG

prednisone

Patients in both arms will be given prednisone chemotherapy

Trial Locations (1)

430071

RECRUITING

DiDeng, Wuhan

All Listed Sponsors
lead

Wuhan University

OTHER